Diana Richardson, MD
Assistant Clinical Professor, NeurologyAbout
Titles
Assistant Clinical Professor, Neurology; Director, National VA Parkinson Disease Consortium , West Haven
Biography
Dr. Richardson is an integral member of our esteemed faculty in the Department of Neurology. She serves as the Director of the Movement Disorder’s Division based at Veterans Administration (VA) Hospital at West Haven, a Yale School of Medicine Affiliate. She initially joined the faculty and established her clinical practice at the West Haven VA in 2007 and at Yale in 2008. Dr. Richardson later made a shift from Yale to the VA to assume the full time role as Director of the Movement Disorders Program. Since the inception of the Parkinson's Disease Consortium at the VA in West Haven in 2008, Dr. Richardson has established and maintained a thriving clinical practice specializing in Parkinson’s Disease and other Movement Disorders. She is also a lead injector in the administration therapeutic botulinum toxins. As an injector, she is recognized amongst her peer for her level of expertise. As a sub-specialist in Movement Disorders, she receives many referral s from Neurologist in the state of CT, NY, MA and RI.
Dr. Diana Richardson is considered a leader in her field both locally and nationally. Nationally, she has served as the interim Medical director for the National American Parkinson’s Disease Association Connecticut Chapter. She is the Director of the Parkinson’s Disease Consortium at West Haven which functions under the auspices of the national VA Parkinson’s Disease Research, Education and Clinical Centers network. Locally she has been coordinator of clinical Research- for the Yale Neurology Movement Disorders Division, 2008-2015. Dr. Richardson is regularly invited as a guest lecturer at the Yale School of Medicine (Physician and Physician’s Assistants programs); Yale school of Nursing; and, Yale and West Haven VA Departments of Medicine, Geriatrics and Neuropsychology. Dr. Richardson has been also been an advocate to encourage healthcare providers, patients and caregivers to be active participants in management of medical illnesses. She promotes education and support group activities within the medical and non-medical communities. At several of these programs has been the guest speaker.
Appointments
Neurology
Assistant Clinical ProfessorPrimary
Other Departments & Organizations
Education & Training
- Fellowship, Movement Disorders
- Yale University School of Medicine, Yale New Haven Hospital (2008)
- Residency
- Stony Brook School of Medicine and University Hospital (2005)
- Fellowship, Clinical Neurophysiology
- Stony Brook School of Medicine and University Hospital (2005)
- Internship
- Hospital Saint Raphael /Yale New Haven (2002)
- MD
- New York Medical College (2001)
- BA
- Wesleyan University (1989)
Research
Research at a Glance
Yale Co-Authors
Publications Timeline
Bahman Jabbari, MD
Publications
2017
IncobotulinumtoxinA in Restless Legs Syndrome (RLS) – a Randomized Double Blind Cross Over Study (P3.029)
Machado D, Richardson D, Jabbari B. IncobotulinumtoxinA in Restless Legs Syndrome (RLS) – a Randomized Double Blind Cross Over Study (P3.029). Neurology 2017, 88 DOI: 10.1212/wnl.88.16_supplement.p3.029.Peer-Reviewed Original Research
2016
Botulinum Toxin Treatment of Chronic Migraine - A Double Blind Study with a Novel Technique Employing Fewer Injections. (P4.124)
Richardson D, Jabbari B. Botulinum Toxin Treatment of Chronic Migraine - A Double Blind Study with a Novel Technique Employing Fewer Injections. (P4.124). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.p4.124.Peer-Reviewed Original ResearchCitationsBotulinum Toxin Treatment of Essential Tremor - A Customized Approach (S27.002)
Rostami R, Chow C, Richardson D, Jabbari B, Machado D. Botulinum Toxin Treatment of Essential Tremor - A Customized Approach (S27.002). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.s27.002.Peer-Reviewed Original ResearchCitationsA Double Blind Investigation of Efficacy and Safety of IncobotulinumtoxinA in Parkinson Disease Tremor- A Customized Injection Approach (S40.007)
Mittal S, Rostami R, Machado D, Richardson D, Jabbari B. A Double Blind Investigation of Efficacy and Safety of IncobotulinumtoxinA in Parkinson Disease Tremor- A Customized Injection Approach (S40.007). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.s40.007.Peer-Reviewed Original ResearchCitations
2015
Incobotulinum toxin-A (inco-A) in restless legs syndrome (RLS) - a randomized double blind cross over study (P7.295)
Rostami R, Machado D, Richardson D, Jabbari B. Incobotulinum toxin-A (inco-A) in restless legs syndrome (RLS) - a randomized double blind cross over study (P7.295). Neurology 2015, 84 DOI: 10.1212/wnl.84.14_supplement.p7.295.Peer-Reviewed Original Research
2014
Focal Injection of Incobotulinum Toxin A Improves Refractory Local Cancer Pain at the Site of Radiation/Surgery (P3.315)
Rostami R, Machado D, Richardson D, Jabbari B. Focal Injection of Incobotulinum Toxin A Improves Refractory Local Cancer Pain at the Site of Radiation/Surgery (P3.315). Neurology 2014, 82 DOI: 10.1212/wnl.82.10_supplement.p3.315.Peer-Reviewed Original ResearchCitations
Academic Achievements & Community Involvement
honor Shining Star
National AwardVA Connecticut Healthcare SystemDetails08/28/2015United Stateshonor Woman of the Year
National AwardNational Association of Professional WomenDetails01/01/2010United States
Get In Touch
Contacts
VA Connecticut Healthcare System
950 Campbell Ave., Neurology 127
West Haven, CT 06516
United States